{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:55:45Z","timestamp":1787165745885,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.annpat.2020.02.015","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T19:12:41Z","timestamp":1584126761000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Les tumeurs h\u00e9r\u00e9ditaires de l\u2019ovaire vues par le pathologiste"],"prefix":"10.1016","volume":"40","author":[{"given":"Florian","family":"Pesce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Devouassoux-Shisheboran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2020.02.015_bib0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0010","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12\u00a0genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annpat.2020.02.015_bib0015","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","article-title":"Breast and ovarian cancer","volume":"348","author":"Wooster","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2020.02.015_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","article-title":"Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management","volume":"3","author":"Lynch","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0030","first-page":"238","article-title":"Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation","volume":"50","author":"Garg","year":"2018","journal-title":"Pathology (Phila.)"},{"key":"10.1016\/j.annpat.2020.02.015_bib0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/ejhg.2016.93","article-title":"The biological effects and clinical implications of BRCA mutations: where do we go from here?","volume":"24","author":"Stoppa-Lyonnet","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.annpat.2020.02.015_bib0040","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.annpat.2020.02.015_bib0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.annpat.2020.02.015_bib0050","doi-asserted-by":"crossref","first-page":"e201204005","DOI":"10.5936\/csbj.201204005","article-title":"Structure-Function Of The Tumor Suppressor BRCA1","volume":"1","author":"Clark","year":"2012","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.annpat.2020.02.015_bib0055","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nsmb.2899","article-title":"Structure and mechanism of action of the BRCA2\u00a0breast cancer tumor suppressor","volume":"21","author":"Shahid","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0060","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4161\/cc.7.18.6679","article-title":"DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells","volume":"7","author":"Mao","year":"2008","journal-title":"Cell Cycle Georget Tex"},{"key":"10.1016\/j.annpat.2020.02.015_bib0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.pathol.3.121806.151422","article-title":"Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment","volume":"4","author":"Venkitaraman","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0070","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00432-009-0607-3","article-title":"BRCA1\u00a0and BRCA2\u00a0germline mutations in Korean ovarian cancer patients","volume":"135","author":"Lim","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jama.2014.12483","article-title":"Population-based screening for BRCA1\u00a0and BRCA2: 2014\u00a0Lasker Award","volume":"312","author":"King","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.annpat.2020.02.015_bib0080","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1\u00a0and BRCA2\u00a0mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2020.02.015_bib0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1\u00a0and BRCA2\u00a0mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.annpat.2020.02.015_bib0090","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1\u00a0or BRCA2\u00a0mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0095","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1\u00a0and BRCA2\u00a0penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1\u00a0and BRCA2\u00a0mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2020.02.015_bib0105","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1186\/s13058-014-0474-y","article-title":"Refined histopathological predictors of BRCA1\u00a0and BRCA2\u00a0mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia","volume":"16","author":"Spurdle","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.annpat.2020.02.015_bib0110","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1\u00a0mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.phrs.2005.02.013","article-title":"Clinical perspectives of PARP inhibitors","volume":"52","author":"Graziani","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.annpat.2020.02.015_bib0120","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1111\/jcmm.13678","article-title":"Potent immunogenicity in BRCA1-mutated patients with high-grade serous ovarian carcinoma","volume":"22","author":"Dai","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.annpat.2020.02.015_bib0125","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.18632\/oncotarget.7277","article-title":"Association and prognostic significance of BRCA1\/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1\/PD-L1\u00a0in high grade serous ovarian cancer","volume":"7","author":"Strickland","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.annpat.2020.02.015_bib0130","doi-asserted-by":"crossref","first-page":"e26191","DOI":"10.1038\/srep26191","article-title":"Assessing mutant p53\u00a0in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing","volume":"6","author":"Cole","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.annpat.2020.02.015_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gore.2019.01.010","article-title":"Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast\/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers","volume":"28","author":"Stewart","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.annpat.2020.02.015_bib0140","doi-asserted-by":"crossref","first-page":"e10110433","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2020.02.015_bib0145","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0155","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic Findings at Risk-Reducing Salpingo-Oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0160","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0170","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","article-title":"Prophylactic salpingo-oophorectomy in a series of 89\u00a0women carrying a BRCA1\u00a0or a BRCA2\u00a0mutation","volume":"109","author":"Laki","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0175","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0180","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2020.02.015_bib0185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2020.02.015_bib0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.dnarep.2018.08.022","article-title":"The comings and goings of PARP-1\u00a0in response to DNA damage","volume":"71","author":"Pascal","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.annpat.2020.02.015_bib0195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1\u00a0and BRCA2\u00a0genotype in ovarian carcinoma","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0200","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrm951","article-title":"Recombinational repair and restart of damaged replication forks","volume":"3","author":"McGlynn","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0205","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/cr0404794","article-title":"DNA mismatch repair: functions and mechanisms","volume":"106","author":"Iyer","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.annpat.2020.02.015_bib0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2559.2009.03392.x","article-title":"DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome","volume":"56","author":"Poulogiannis","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2020.02.015_bib0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10689-004-5811-3","article-title":"The incidence of Lynch syndrome","volume":"4","author":"de la Chapelle","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAS.0000000000001165","article-title":"Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104\u00a0Ovarian Endometrioid Carcinomas","volume":"43","author":"Bennett","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0225","first-page":"447","article-title":"Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles","volume":"28","author":"Kelemen","year":"2017","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.annpat.2020.02.015_bib0230","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6\u00a0genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.annpat.2020.02.015_bib0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","article-title":"Ovarian cancer in Lynch syndrome; a systematic review","volume":"55","author":"Helder-Woolderink","year":"2016","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.annpat.2020.02.015_bib0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygyno.2018.03.060","article-title":"Characteristics of Lynch syndrome associated ovarian cancer","volume":"150","author":"Woolderink","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s13244-015-0425-x","article-title":"Do hereditary syndrome-related gynecologic cancers have any specific features?","volume":"6","author":"Neto","year":"2015","journal-title":"Insights Imaging"},{"key":"10.1016\/j.annpat.2020.02.015_bib0250","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","article-title":"The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome","volume":"21","author":"Crosbie","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.annpat.2020.02.015_bib0255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/1940-6207.CAPR-11-0288","article-title":"Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing","volume":"5","author":"Bartley","year":"2012","journal-title":"Cancer Prev Res Phila Pa"},{"key":"10.1016\/j.annpat.2020.02.015_bib0260","unstructured":"Principales recommandations de prise en charge des patients porteurs d\u2019une mutation d\u2019un g\u00e8ne MMR dans le syndrome de Lynch - Ref\u00a0: RECOMMR09, 2009. https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Principales-recommandations-de-prise-en-charge-des-patients-porteurs-d-une-mutation-d-un-gene-MMR-dans-le-syndrome-de-Lynch."},{"key":"10.1016\/j.annpat.2020.02.015_bib0265","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.3802\/jgo.2019.30.e46","article-title":"Immunotherapy in endometrial cancer: new scenarios on the horizon","volume":"30","author":"Di Tucci","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0270","first-page":"e10050143","article-title":"DICER1\u00a0Syndrome: DICER1\u00a0Mutations in Rare Cancers","volume":"10","author":"Robertson","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2020.02.015_bib0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2020.02.015_bib0280","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"Foulkes","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jmg.2010.083790","article-title":"DICER1\u00a0syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome","volume":"48","author":"Slade","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.annpat.2020.02.015_bib0290","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1\u00a0and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2020.02.015_bib0295","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-198508000-00001","article-title":"Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207\u00a0cases","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0300","unstructured":"Elsevier: Diagnostic Pathology: Gynecological, 2nd Edition: Nucci & Oliva, 2018. https:\/\/www.elsevier.ca\/ca\/product.jsp?isbn=9780323548151."},{"key":"10.1016\/j.annpat.2020.02.015_bib0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1102903","article-title":"Recurrent Somatic DICER1\u00a0Mutations in Nonepithelial Ovarian Cancers","volume":"366","author":"Heravi-Moussavi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2020.02.015_bib0310","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.12747","article-title":"DICER1\u00a0and FOXL2\u00a0mutations in ovarian sex cord-stromal tumours: a GINECO Group study","volume":"68","author":"Goulvent","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2020.02.015_bib0315","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/PAS.0000000000000895","article-title":"DICER1\u00a0Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors","volume":"41","author":"de Kock","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0320","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00428-016-1922-0","article-title":"The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1\u00a0syndrome","volume":"468","author":"Durieux","year":"2016","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4174\/astr.2014.86.6.325","article-title":"Peutz-Jeghers syndrome with germline mutation of STK11","volume":"86","author":"Chae","year":"2014","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.annpat.2020.02.015_bib0330","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cgh.2005.11.005","article-title":"Peutz-Jeghers syndrome and management recommendations","volume":"4","author":"Giardiello","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0335","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/1097-0142(19821001)50:7<1384::AID-CNCR2820500726>3.0.CO;2-5","article-title":"Ovarian sex cord tumor with annular tubules: review of 74\u00a0cases including 27\u00a0with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix","volume":"50","author":"Young","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0340","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00004347-199407000-00010","article-title":"Oxyphilic Sertoli cell tumor of the ovary: a report of three cases, two in patients with the Peutz-Jeghers syndrome","volume":"13","author":"Ferry","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0345","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.annpat.2020.02.015_bib0350","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature04866","article-title":"ATM stabilizes DNA double-strand-break complexes during V(D)J recombination","volume":"442","author":"Bredemeyer","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2020.02.015_bib0355","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/archdischild-2016-310477","article-title":"Ataxia telangiectasia: presentation and diagnostic delay","volume":"102","author":"Devaney","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.annpat.2020.02.015_bib0360","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejpn.2007.04.001","article-title":"Alpha fetoprotein is increasing with age in ataxia-telangiectasia","volume":"11","author":"Stray-Pedersen","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.12.3.251","article-title":"Specific chromosome aberrations in ataxia telangiectasia","volume":"12","author":"Oxford","year":"1975","journal-title":"J Med Genet"},{"key":"10.1016\/j.annpat.2020.02.015_bib0370","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/08880010701451434","article-title":"Dysgerminoma in a child with ataxia-telangiectasia","volume":"24","author":"Koksal","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0375","first-page":"165","article-title":"Gonadoblastoma and dysgerminoma with ataxia-telangiectasia","volume":"12","author":"Buyse","year":"1976","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.annpat.2020.02.015_bib0380","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0090-8258(88)90219-3","article-title":"Ataxia-telangiectasia and endodermal sinus tumor of the ovary: report of a case","volume":"29","author":"Pecorelli","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0385","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of a mutated p53\u00a0gene in a cancer-prone family with Li-Fraumeni syndrome","volume":"348","author":"Srivastava","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2020.02.015_bib0390","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.annpat.2020.02.015_bib0395","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53\u00a0network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2020.02.015_bib0400","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.14461","article-title":"Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition","volume":"176","author":"Valdez","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0405","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/gepi.1370120103","article-title":"ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data","volume":"12","author":"Le Bihan","year":"1995","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0410","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PGP.0000000000000365","article-title":"Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix","volume":"36","author":"Tandon","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0415","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4\u00a0mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2020.02.015_bib0420","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150\u00a0cases","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.015_bib0425","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/his.12988","article-title":"Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics","volume":"69","author":"Clarke","year":"2016","journal-title":"Histopathology"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649820300511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649820300511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:34:18Z","timestamp":1759332858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649820300511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0242649820300511"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2020.02.015","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les tumeurs h\u00e9r\u00e9ditaires de l\u2019ovaire vues par le pathologiste","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2020.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}